Magnetic Resonance Imaging in the Postoperative Evaluation of the Patient with Congenital Heart Disease

Published on 13/02/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1280 times

CHAPTER 50 Magnetic Resonance Imaging in the Postoperative Evaluation of the Patient with Congenital Heart Disease

In recent years, advances in pediatric cardiovascular surgery, catheter-based interventional therapies, intensive care, and medical management have dramatically changed the landscape of the field of congenital heart disease (CHD). The complexity of the anatomy and physiology of patients surviving with CHD is increasing exponentially; the majority will survive to adulthood, and the need for reintervention is common. This changing field is placing new demands on imaging to plan medical management as well as to identify the need for and timing of reintervention. A number of imaging modalities are available to the clinician and imaging specialist when it comes to these evaluations. Given its ability to assess both anatomy and function, magnetic resonance imaging (MRI) holds a unique and growing position among these.

Echocardiography has been and remains a mainstay of imaging in CHD. Despite its importance in rapid diagnosis and follow-up, it has limitations in the evaluation of the postoperative patient with CHD. Postoperative scar, chest wall deformities, overlying lung tissue, and large body size as the patient ages often result in suboptimal transthoracic echocardiographic windows. Transesophageal echocardiography, although providing improved acoustic windows, is limited by its small field of view and more invasive nature, often requiring deep sedation or general anesthesia.

Cardiac catheterization, employing x-ray fluoroscopy and contrast angiography, has an expanding role in minimally invasive interventions, but its role as a diagnostic procedure is rapidly diminishing. This is in part due to its limitation as a two-dimensional projection imaging technique with poor soft tissue contrast and the substantial ionizing radiation exposure involved; also, both diagnostic analysis and functional analysis are often better performed with noninvasive imaging techniques.

Computed tomography (CT) has been useful in evaluating vascular anatomy, and with the advent of high-resolution CT and cardiac gating, it has emerged as a useful tool for assessment of intracardiac anatomy, coronary artery anatomy, and myocardial function. Nevertheless, the temporal resolution of cardiac CT remains limited, and advances in CT imaging technology have often come with increases in exposure to ionizing radiation.

MRI has emerged during the past few decades as an alternative, complementary, and frequently superior imaging modality for the investigation of anatomy and function in the postoperative CHD patient. It has many advantages over other imaging modalities. It does not require the use of iodinated contrast agents and does not involve exposure to ionizing radiation. This is particularly important in a population of patients who have been and continue to be exposed to large doses of contrast agent and radiation during hemodynamic and interventional catheterization. In addition, many of these patients are children, who are more susceptible to the adverse effects of radiation. Major advances in MRI hardware and software, including advanced coil design, faster gradients, new pulse sequences, and faster image reconstruction techniques, allow rapid, high-resolution imaging of complex anatomy and accurate, quantitative assessment of function.

This chapter highlights the MRI techniques frequently employed to evaluate the anatomy and physiology of the postoperative CHD patient. It provides information about the general application of MRI in this population of patients as well as sample protocols and guidelines for its use in the more commonly encountered lesions referred for MRI.

POSTOPERATIVE ASSESSMENT

A number of MRI techniques are useful to the examination of the anatomy and physiology of the postoperative CHD patient. These techniques are detailed in Chapters 13 to 17. Here, their importance to this population is highlighted.

Cine Magnetic Resonance Imaging

ECG-gated gradient-echo sequences can be employed to provide multiple images throughout the cardiac cycle in prescribed anatomic locations. Display of these images in a cine mode permits visualization of the dynamic motion of the heart and vessels.13 Cine MRI techniques, at a minimum, allow assessment of anatomy. More important, such techniques allow qualitative and quantitative assessment of function. Specifically, cine MRI permits quantification of chamber volumes, myocardial mass, and ventricular function. Further, cine MRI allows qualitative assessment of focal and global wall motion abnormalities, qualitative and quantitative assessment of valve disease (including the mechanism and severity of valve regurgitation and the location and severity of valve stenoses), identification and quantification of intracardiac and extracardiac shunts, and visualization of other areas of flow turbulence.

Cine MRI is the principal tool used to quantitatively assess ventricular function. Such techniques, both fast gradient-echo47 and balanced steady-state free precession,1,2 have been extensively evaluated and validated.8,9 Briefly, evaluation of function begins with obtaining a series of contiguous cine slices along the short axis of the ventricles, extending from base to apex. The prescription of such slices should be performed from a true four-chamber view at end-diastole to ensure coverage of the entire ventricular mass (Fig. 50-1). These images are played back in a cine loop, and the end-systolic and end-diastolic phases are chosen. The endocardial borders are traced at both time points, and the epicardial borders are traced at one of the two time points (Fig. 50-2). Ventricular volumes are then calculated as the sum of the traced volumes (area × slice thickness). Myocardial mass is calculated as the myocardial muscle volume × 1.05 g/mm3 (density of myocardium). From these data, ventricular end-diastolic volume, end-systolic volume, stroke volume, ejection fraction, myocardial mass, and mass-to-volume ratio can be calculated for both the right and left ventricles. Most computer workstation software packages for cardiac MRI analysis provide semiautomated postprocessing tools to maximize efficiency.

Spin-Echo (Black Blood) Imaging

ECG-gated spin-echo sequences (black blood imaging) represent another important tool for imaging in the postoperative CHD patient. Despite providing only static information, black blood imaging has many benefits in this population. It allows assessment of anatomy with thin slices, high spatial resolution, and excellent blood-myocardium and blood–vessel wall contrast (Fig. 50-3). Black blood techniques are superb for evaluation of the spatial relationship between cardiovascular and other intrathoracic structures, such as the chest wall and the tracheobronchial tree. These features hold particular relevance in delineation of complicated postsurgical cardiac anatomy. Such techniques are also less susceptible to artifact from metallic implanted devices, such as stents, coils, occluder devices, clips, and sternal wires, which are commonly seen in the postoperative CHD patient.

Flow Quantification

Electrocardiography-gated gradient-echo sequences with flow-encoding gradients are used to quantify the velocity and flow of blood (Fig. 50-4).10 These sequences are referred to as velocity-encoded cine MRI or phase contrast MRI. Two-dimensional velocity-encoded cine MRI sequences are commonly used in clinical practice. They can be used to quantify cardiac output, pulmonary-to-systemic flow ratio (shunt), valvular regurgitation, differential lung perfusion, and coronary flow reserve. They can be used to observe the location and severity of flow obstruction. In addition, velocity-encoded cine MRI assessment of flow is useful for corroboration of volumetric data obtained with cine imaging to ensure the interpreting physician that the data obtained are accurate.

Newer velocity-encoded cine MRI sequences allow resolution of velocity vectors in three directions, with spatial coverage of a three-dimensional volume, temporally resolved throughout the cardiac cycle. Such techniques have been coined seven-dimensional flow encoding.11,12 These techniques have the advantage of providing complete spatial and temporal resolution of velocity with a higher signal-to-noise ratio than in two-dimensional methods. Postprocessing tools permit the construction of vector field plots that highlight the intracardiac and intravascular nature of flow. Although they are currently limited by long scan durations, faster imaging techniques will likely allow such methods to reach clinical practice in the near future.

Gadolinium-Enhanced Three-Dimensional Angiography

Three-dimensional magnetic resonance angiography (MRA) sequences are typically not ECG-gated and thus do not allow optimal assessment of intracardiac structures. Regardless, such techniques provide excellent depiction of arterial and venous vascular structures (Fig. 50-5). In the population of postoperative CHD patients, three-dimensional MRA fills a significant diagnostic role. It can be used to diagnose systemic arterial anomalies, such as aortopulmonary collaterals, shunts, vascular rings, and coarctation. It is useful in the diagnosis of pulmonary arterial abnormalities, such as focal and diffuse stenoses and abnormal distal arborization patterns. Three-dimensional MRA methods are also useful for investigation of systemic and pulmonary venous abnormalities, both congenital anomalies and postoperative abnormalities. Finally, three-dimensional MRA is useful for evaluation of the relation between vascular and other thoracic structures. With the development of faster imaging techniques, ECG-gated three-dimensional MRA sequences are becoming more practical, allowing evaluation of intracardiac anatomy and acquisition of time-resolved three-dimensional MRA data sets.13

Coronary Artery Imaging, Perfusion Imaging, and Myocardial Viability

Coronary artery abnormalities and ischemia are important issues to be investigated in postoperative CHD patients. Not only is this population of patients aging sufficiently to develop atherosclerotic coronary artery disease, they also commonly have congenitally abnormal or postoperatively acquired coronary artery lesions. It is not uncommon to find an anomalous origin or course of the left or right coronary artery, postsurgical coronary obstruction (i.e., after arterial switch for transposition of the great arteries), coronary artery thrombus (Fig. 50-6), or abnormal fistulous connections (i.e., pulmonary atresia with intact ventricular septum and right ventricle–dependent coronary circulation). Identification of such abnormalities is often critical to planning of reintervention or medical management. There is growing evidence to support that myocardial delayed hyperenhancement in a number of subsets of postoperative CHD patients is predictive of poor outcome, including patients with tetralogy of Fallot (Fig. 50-7).14,15 Delayed hyperenhancement has been observed in other postoperative patients with CHD as well, the significance of which is being explored and elucidated.16,17 In summary, although it is still not as robust as routine coronary artery angiography with x-ray fluoroscopy or ECG-gated CT angiography at investigating distal coronary artery lesions, MRI can image proximal coronary arteries well,1821 evaluate myocardial perfusion and viability,2226 and allow stress testing,2730 all noninvasively without exposure to contrast agents and ionizing radiation.

IMAGING TECHNIQUE AND FINDINGS

Tetralogy of Fallot

Tetralogy of Fallot (TOF), the most common form of cyanotic CHD, accounts for approximately 10% of all CHD and represents a large portion of postoperative CHD patients. This malformation consists of one embryologic abnormality, namely, anterior malalignment of the infundibular septum, leading to four constant features: malalignment ventricular septal defect, subvalvular (infundibular) and valvular pulmonary stenosis, overriding aorta, and right ventricular hypertrophy. Patients with TOF compose a varied group ranging from TOF with pulmonary atresia and multiple aortopulmonary collateral vessels to TOF with mild pulmonary stenosis.

Repair is also varied and has evolved during the past few decades. Early repair in the first few months of life is now possible and recommended as standard of care. Older patients referred for MRI will likely have undergone initial palliation to augment pulmonary blood flow (e.g., Blalock-Taussig, Waterston, or Potts shunt) with later definitive repair. The goals of definitive repair are to close the ventricular septal defect and to relieve right ventricular outflow tract obstruction (placement of a right ventricle–to–pulmonary artery conduit in patients with pulmonary atresia, placement of a transannular patch in those with severe pulmonary stenosis, or infundibular muscle resection in those with mild pulmonary stenosis).

Increasingly rare, imaging specialists will continue to see patients with only palliated TOF, pulmonary atresia, and multiple aortopulmonary collaterals. The goal of MRI in these patients is to delineate the anatomy of the pulmonary vascular bed and aortopulmonary collaterals. In this way, MRI can aid in determination of a patient’s candidacy for definitive repair.

Postoperative Management

Most patients with repaired TOF will have a certain degree of pulmonary regurgitation or stenosis, which has been shown to result in right ventricular dilation and dysfunction. In addition, progressive right ventricular dilation often leads to tricuspid valve annular stretch and ultimately regurgitation, which perpetuates continued right ventricular dilation. In addition, many patients with repaired TOF will have abnormal peripheral pulmonary vasculature and residual aortopulmonary collaterals, all of which contribute to their hemodynamic burden. Multiple studies in the recent literature have demonstrated that right ventricular dilation and dysfunction, as determined by MRI, predict adverse outcomes such as symptoms of right-sided heart failure, major arrhythmic events, and even death.31 Right ventricular dilation and dysfunction will often be detected by MRI before the onset of obvious clinical symptoms. In addition, delayed hyperenhancement has been shown to correlate with adverse outcomes in patients with repaired TOF.32

For these reasons, MRI is useful in this population to delineate anatomy; to identify distal pulmonary vascular lesions; to identify the location and severity of pulmonary stenosis; to quantify pulmonary regurgitation; to quantify right and left ventricular mass, volumes, and function; and to identify regions of myocardial scar.

MRI for a patient with TOF may include the following:

At many institutions, MRI has become the standard of care for initial delineation of anatomy, monitoring for residual hemodynamic lesions, and surgical planning in patients with unrepaired and repaired TOF. A baseline study should be obtained in late childhood when sedation no longer is necessary (i.e., 6 to 8 years of age). Serial MRI evaluation should be performed every 1 to 4 years on the basis of initial findings and clinical symptoms (i.e., more frequently if there is pulmonary stenosis, moderate to severe pulmonary regurgitation, significant right ventricular dilation or dysfunction, left ventricular dysfunction, or clinical symptoms). If there is pulmonary stenosis, MRI should be paired with echocardiography.

Transposition of the Great Arteries

D-Transposition of the great arteries (D-TGA), in which the aorta arises anteriorly and rightward from the right ventricle and the pulmonary artery arises posterior and leftward from the left ventricle, is the most common form of TGA (accounting for 5% to 7% of all children born with CHD) and is a common form of cyanotic CHD (second only to TOF). This circulation is typically not compatible with life unless surgery is performed to redirect deoxygenated flow to the lungs and oxygenated flow to the body. Until the mid-1980s, this defect was surgically corrected with an atrial-level switch (Senning or Mustard procedure). The arterial switch (Jatene procedure) became popular in the mid-1980s and remains the standard of care in this population of patients.

Postoperative Management

After an atrial-level switch, patients suffer a number of residual hemodynamic burdens. The most important of these is systemic right ventricular failure as the right ventricle is not morphologically designed to handle a systemic afterload. Right ventricular dilation and failure are often accompanied by tricuspid (systemic atrioventricular valve) regurgitation, which leads to worsening right ventricular dilation and dysfunction. Patients who have undergone an atrial-level switch also suffer systemic or pulmonary venous baffle obstruction and baffle leaks with either right-to-left or left-to-right shunting, depending on the anatomy.

Patients who have undergone an arterial switch have the benefit of having a left ventricle as the systemic pumping chamber but still retain a number of potential hemodynamic burdens, such as supra-aortic and suprapulmonary stenoses at the suture lines, branch pulmonary artery stenoses secondary to stretch of the pulmonary arteries across the ascending aorta, and coronary ostial occlusions at the site of coronary artery reimplantation.

MRI for a patient with D-TGA who has undergone an atrial-level switch procedure may include the following:

Guidelines for MRI in patients with D-TGA who have undergone an atrial-level switch procedure include a baseline investigation and serial follow-up evaluation. The information uniquely provided by MRI includes quantitative systemic right ventricular function, visualization of the synchrony (or asynchrony) of ventricular contraction, atrioventricular valve regurgitation, systemic venous or pulmonary venous pathway obstruction, and baffle leaks (with cine imaging and quantification of systemic-to-pulmonary flow ratio). Depending on systemic right ventricular function, other anatomic and physiologic abnormalities, and clinical symptoms, MRI should be repeated every 2 to 4 years to monitor these.

MRI for a patient with D-TGA who has undergone an arterial switch procedure may include the following:

MRI is useful for baseline and serial evaluation of patients with D-TGA who have undergone arterial switch. The information uniquely provided by MRI includes evaluation of the great vessels (supra-aortic and suprapulmonary stenosis and branch pulmonary artery obstruction). In addition, the coronary artery ostia and proximal coronary arteries can be evaluated. Stress MRI (dipyridamole, adenosine, or dobutamine) can additionally allow evaluation of perfusion defects and coronary flow reserve. Finally, MRI offers an assessment of ventricular function. Depending on baseline findings and clinical symptoms, MRI can be repeated serially.

Coarctation of the Aorta

MRI is useful for delineation of anatomy and physiology in patients after repair of coarctation of the aorta.33,34 This can be monitored with serial MRI to identify the need for and to ensure appropriate timing of reintervention.

Coarctation of the aorta is a common form of CHD. Simple coarctation of the aorta accounts for 5% to 8% of all patients born with CHD and is a component of many more complex lesions. In coarctation of the aorta, ductal tissue surrounds the aortic isthmus, and with ductal closure, there is constriction leading to arch obstruction. If it is diagnosed in the newborn period, surgical repair with resection of the obstruction and end-to-end anastomosis is the preferred therapy. If it is diagnosed later in life, catheter-based intervention with balloon dilation or stenting of the obstruction can be performed as an alternative to surgery. Patients with native or repaired coarctation of the aorta often suffer aortic complications, such as restenosis, aneurysm formation of the ascending aorta or repair site, dissection, systemic hypertension with left ventricular hypertrophy, and early coronary artery disease. These complications are often asymptomatic and go unrecognized until it is too late.

Echocardiographic assessment is often limited by poor acoustic windows. Although CT angiography provides anatomic detail, it is unable to characterize flow and the effect of the obstruction on the myocardium. MRI can noninvasively enhance our understanding of coarctation severity, and clinical assessment combined with MRI as a primary imaging modality can be more cost-effective than an approach using echocardiography as a primary imaging modality.35,36

Postoperative Management

The initial goal of a cardiac MRI examination in a patient after repair of coarctation of the aorta is delineation of the anatomy. This includes anatomic characterization of recurrent or residual obstruction, relationship of the obstruction to other arch vessels (which is necessary for planning of surgical or catheter-based interventions), arch anatomy (e.g., aortic root or ascending aorta dilation, hypoplasia of the arch, post-stenotic dilation of the descending aorta, aneurysm at site of repair), and number of collateral vessels. The second goal is to evaluate the effect of the obstruction or resultant systemic hypertension on the myocardium, including left ventricular myocardial mass and left ventricular function. The final goal is to ascertain the physiologic severity of the obstruction by evaluating the nature of flow at the obstruction and in the descending aorta.

MRI for a patient with repaired coarctation of the aorta may include the following:

In general, MRI should be used to evaluate anyone older than 6 years after repair of coarctation of the aorta with concern for recurrent or residual obstruction, aneurysm formation, or systemic hypertension. MRI should be used in younger children if questions remain after echocardiography. In patients who have undergone apparently successful repair, MRI should be obtained at baseline in late childhood when sedation is no longer necessary (i.e., 6 to 8 years of age). It should be repeated every 6 months to 5 years, depending on initial findings.

Single Ventricle After Fontan Palliation

Patients born with complex CHD and single-ventricle physiology (i.e., tricuspid atresia, hypoplastic left heart syndrome, pulmonary atresia with intact ventricular septum) represent a spectrum of disease severity, depending on their initial anatomy. In the current era, they typically undergo several surgical procedures during the first several years of life to provide a stable cardiopulmonary physiology. The first of these procedures is usually performed in the neonatal period and is directed at recruiting the single ventricle as the systemic pumping chamber and providing controlled pulmonary blood flow. The subsequent procedures involve sequential conversion to a physiology of separated systemic and pulmonary circulations with passive pulmonary blood flow (elimination of intracardiac mixing). The final circulation is named the Fontan circulation after the French surgeon who developed and first performed it in humans.37 This palliation improves the patient’s cardiovascular efficiency and provides nearly normal systemic arterial oxygen saturations, but the physiology remains abnormal.

Postoperative Management

These patients suffer many complications. First, as a result of the passive nature of pulmonary blood flow, they develop high right-sided filling pressures, dilated Fontan pathways, and atrial arrhythmias. As a result of high filling pressures, they often form systemic-to-pulmonary venous collaterals, which lead to cyanosis. As a result of sluggish pulmonary blood flow, they have poor left-sided preload and diminished output despite normal contractility. They often have single right ventricles that ultimately fail in the face of systemic afterload. They may have valvular disease that increases the pressure or volume load of the single ventricle. All of this inevitable pathophysiology must be monitored to ensure timely medical, catheter-based, and surgical interventions that may improve the patient’s clinical status.

The goal of a cardiac MRI evaluation of patients with single-ventricle physiology is first the delineation of anatomy. This postsurgical anatomy is often complex and often unexpected. The second goal is the characterization of physiology, including valvular disease, myocardial function, and flow assessment. A cardiac MRI protocol for such a patient may include the following:

Guidelines for the use of cardiac MRI in the setting of palliated single-ventricle physiology need to be tailored to the individual patient. If there are no concerns early, baseline cardiac MRI should be obtained in late childhood when sedation is no longer necessary (i.e., 6 to 8 years of age). Serial examinations should be performed, the frequency of which should be dictated by clinical status. Obviously, if there are concerns earlier (i.e., valvular disease, myocardial dysfunction, arterial or venous abnormalities, baffle leaks), MRI can be performed under sedation or general anesthesia.

KEY POINTS

REFERENCES

1 Plein S, Bloomer TN, Ridgway JP, et al. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging. 2001;14:230-236.

2 Carr JC, Simonetti O, Bundy J, et al. Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology. 2001;219:828-834.

3 Weiger M, Pruessmann KP, Boesiger P. Cardiac real-time imaging using SENSE. SENSitivity Encoding scheme. Magn Reson Med. 2000;43:177-184.

4 Hernandez RJ, Aisen AM, Foo TK, Beekman RH. Thoracic cardiovascular anomalies in children: evaluation with a fast gradient-recalled-echo sequence with cardiac-triggered segmented acquisition. Radiology. 1993;188:775-780.

5 Furber A, Balzer P, Cavaro-Menard C, et al. Experimental validation of an automated edge-detection method for a simultaneous determination of the endocardial and epicardial borders in short-axis cardiac MR images: application in normal volunteers. J Magn Reson Imaging. 1998;8:1006-1014.

6 Bax JJ, Lamb H, Dibbets P, et al. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol. 2000;86:1299-1305.

7 Bellenger NG, Marcus NJ, Davies C, et al. Left ventricular function and mass after orthotopic heart transplantation: a comparison of cardiovascular magnetic resonance with echocardiography. J Heart Lung Transplant. 2000;19:444-452.

8 Pennell DJ. Ventricular volume and mass by CMR. J Cardiovasc Magn Reson. 2002;4:507-513.

9 Lorenz CH. The range of normal values of cardiovascular structures in infants, children, and adolescents measured by magnetic resonance imaging. Pediatr Cardiol. 2000;21:37-46.

10 Varaprasathan GA, Araoz PA, Higgins CB, Reddy GP. Quantification of flow dynamics in congenital heart disease: applications of velocity-encoded cine MR imaging. Radiographics. 2002;22:895-905.

11 Markl M, Alley MT, Pelc NJ. Balanced phase-contrast steady-state free precession (PC-SSFP): a novel technique for velocity encoding by gradient inversion. Magn Reson Med. 2003;49:945-952.

12 Markl M, Chan FP, Alley MT, et al. Time-resolved three-dimensional phase-contrast MRI. J Magn Reson Imaging. 2003;17:499-506.

13 Zhang H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging. 2007;25:13-25.

14 Babu-Narayan SV, Kilner PJ, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405-413.

15 Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology. 2005;237:868-871.

16 Harris MA, Johnson TR, Weinberg PM, Fogel MA. Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2007;133:676-681.

17 Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol. 2004;93:657-661.

18 Weber OM, Martin AJ, Higgins CB. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med. 2003;50:1223-1228.

19 Weber OM, Pujadas S, Martin AJ, Higgins CB. Free-breathing, three-dimensional coronary artery magnetic resonance angiography: comparison of sequences. J Magn Reson Imaging. 2004;20:395-402.

20 Spuentrup E, Katoh M, Buecker A, et al. Free-breathing 3D steady-state free precession coronary MR angiography with radial k-space sampling: comparison with cartesian k-space sampling and cartesian gradient-echo coronary MR angiography—pilot study. Radiology. 2004;231:581-586.

21 Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional x-ray angiography: a meta-analysis. J Am Coll Cardiol. 2004;44:1867-1876.

22 Plein S, Radjenovic A, Ridgway JP, et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology. 2005;235:423-430.

23 Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432-437.

24 Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.

25 Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Cardiol Clin. 2007;25:35-56.

26 Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215-223.

27 Akhtar M, Ordovas K, Martin A, et al. Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy. Congest Heart Fail. 2007;13:130-135.

28 Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769-1776.

29 Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47:1427-1432.

30 Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318-3326.

31 Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008;94:211-216.

32 Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004;43:1068-1074.

33 Bogaert J, Kuzo R, Dymarkowski S, et al. Follow-up of patients with previous treatment for coarctation of the thoracic aorta: comparison between contrast-enhanced MR angiography and fast spin-echo MR imaging. Eur Radiol. 2000;10:1847-1854.

34 Pujadas S, Reddy GP, Weber O, et al. Phase contrast MR imaging to measure changes in collateral blood flow after stenting of recurrent aortic coarctation: initial experience. J Magn Resonance Imaging. 2006;24:72-76.

35 Nielsen JC, Powell AJ, Gauvreau K, et al. Magnetic resonance imaging predictors of coarctation severity. Circulation. 2005;111:622-628.

36 Therrien J, Thorne SA, Wright A, et al. Repaired coarctation: a “cost-effective” approach to identify complications in adults. J Am Coll Cardiol. 2000;35:997-1002.

37 Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240-248.